Skip to content

US · IOSP · CHEMICALS - SPECIALTY

Innospec Inc. (IOSP) intrinsic value and stock valuation

$75.56as of 2026-11-21 · Mkt cap 2.27B

Data updated · price as of 2026-11-21

Fairly valuedIC value is within 20% of the price. The exact IC value, upside and the fair-value band are available with Pro.
P/E
Pro
P/B
Pro
P/S
Pro

Price history

Price charts, the InvestorsCraft value line, and the fair-value band are Pro features.

Innospec Inc. DCF and intrinsic value

InvestorsCraft values IOSP with the Chepakovich two-stage DCF model — currently rated fairly valued. How the model works · Run your own DCF prefilled from IOSP’s statements →

Innospec Inc. Graham Number

Graham Number: $75.16d — the price is above the Graham Number. Formula √(22.5 × EPS × BVPS) using the latest diluted EPS and book value per share. Guide · Calculator →

Basic Materials · Chemicals - Specialty Englewood, CO 80112 innospec.com

How the business is doing

Fiscal 2011–2025, USD

Revenue
$1.78B+8.3% 5y CAGRd
20112025
Net income
$116.6M+32.4% 5y CAGRd
20112025
Free cash flow
$88M-5.4% 5y CAGRd
20112025
Total equity
$1.33B+7.1% 5y CAGRd
20112025

Is it expensive?

Each multiple against its own 15-year range, or against peers where no history is available

P/E
Pro
with Pro
P/B
Pro
with Pro
P/S
Pro
with Pro
EV/EBITDA
Pro
with Pro
P/EG
Pro
with Pro
P/TBV
Pro
with Pro

Peers

Same-industry companies, ranked by market cap

Peer comparison

The peer comparison table is shown only to users with a Pro subscription.

Financials

Statements by fiscal year

Fiscal 2011–2025, USD
20252024202320222021
Revenue$1.78B$1.85B$1.95B$1.96B$1.48B
Operating income$156.3M$177.9M$161.6M$187.3M$132.1M
Net income$116.6M$35.6M$139.1M$133M$93.1M
EPSd$4.67M$1.42M$5.56M$5.32M$3.75M
Operating cash flow$138.3M$184.5M$207.3M$81.7M$93.2M
Capital expenditure-$-50.3M-$-41.4M-$-62.1M-$-42.3M-$-39.1M
Free cash flow$88M$143.1M$145.2M$39.4M$54.1M
Total assets$1.83B$1.73B$1.71B$1.6B$1.57B
Total debt$52.7M$44.9M$45.2M$45.3M$35.6M
Net debt-$-239.8M-$-244.3M-$-158.5M-$-101.8M-$-106.2M
Total equity$1.33B$1.22B$1.15B$1.04B$1.03B
Cash and short-term investments$292.5M$289.2M$203.7M$147.1M$141.8M
Income statement
20252024202320222021
Revenue$1.78B$1.85B$1.95B$1.96B$1.48B
Cost of revenue$1.29B$1.3B$1.36B$1.38B$1.05B
Gross profit$492.4M$542.9M$591.1M$586.7M$434.9M
Research and development expenses$51M$47.8M$41.7M$38.7M$37.4M
Selling, general and administrative expenses$285.1M$314M$387.8M$360.7M$267.2M
Other expenses$0.00$3.2M$0.00$0.00-$-1.8M
Operating expenses$336.1M$365M$429.5M$399.4M$302.8M
Cost and expenses$1.62B$1.67B$1.79B$1.78B$1.35B
Interest income$9.2M$0.00$0.00$0.00$0.00
Interest expense$0.00$0.00$0.00$1.1M$1.5M
Depreciation and amortization$49.3M$43.5M$39.3M$40.1M$42.7M
Ebitda$187.4M$224.6M$213.7M$225.8M$173M
Operating income$156.3M$177.9M$161.6M$187.3M$132.1M
Total other income/expenses, net-$-18.2M-$-136.7M$12.8M-$-2.7M$2.3M
Income before tax$138.1M$41.2M$174.4M$184.6M$134.4M
Income tax expense$21.5M$5.6M$35.3M$51.6M$41.3M
Net income$116.6M$35.6M$139.1M$133M$93.1M
Weighted average shares outstanding$24.9M$24.9M$24.9M$24.8M$24.7M
Weighted average diluted shares outstanding$25M$25.1M$25M$25M$24.9M
Balance sheet
20252024202320222021
Cash and short-term investments$292.5M$289.2M$203.7M$147.1M$141.8M
Net receivables$342.3M$341.7M$359.8M$334.6M$284.5M
Inventory$329.3M$301M$300.1M$373.1M$277.6M
Total current assets$1B$956.6M$885.7M$872.6M$728.1M
Property, plant and equipment, net$338.8M$314.5M$313.4M$266.2M$249.8M
Goodwill and intangible assets$466.7M$447.9M$456.6M$403.8M$421.8M
Long-term investments$0.00$0.00$0.00$0.00$0.00
Total non-current assets$827.8M$778.1M$821.7M$731.1M$842.8M
Total assets$1.83B$1.73B$1.71B$1.6B$1.57B
Accounts payable$174.7M$163.8M$163.6M$165.3M$148.7M
Short-term debt$15.9M$13.9M$13.6M$13.9M$12.5M
Deferred revenue$0.00$0.00$0.00$0.00$0.00
Total current liabilities$360.1M$371.4M$371.5M$405.8M$336.6M
Long-term debt$36.8M$31M$31.6M$31.4M$23.1M
Deferred revenue, non-current$0.00$0.00$0.00$0.00$0.00
Total non-current liabilities$139.4M$147.2M$186.3M$157.5M$201.3M
Capital lease obligations$52.7M$44.9M$45.2M$45.3M$35.6M
Total liabilities$499.5M$518.6M$557.8M$563.3M$537.9M
Common stock$300K$300K$300K$300K$300K
Retained earnings$1.1B$1.03B$1.03B$924.2M$822.9M
Accumulated other comprehensive income (loss)-$-34.7M-$-91M-$-148.1M-$-145.2M-$-46.9M
Total equity$1.33B$1.22B$1.15B$1.04B$1.03B
Total investments$0.00$0.00$0.00$0.00$0.00
Total debt$52.7M$44.9M$45.2M$45.3M$35.6M
Net debt-$-239.8M-$-244.3M-$-158.5M-$-101.8M-$-106.2M
Cash flow statement
20252024202320222021
Net income$116.6M$35.6M$139.1M$133M$93.1M
Depreciation and amortization$43.6M$43.5M$39.3M$40.1M$42.7M
Stock-based compensation$8.1M$8.5M$8M$6.7M$4.4M
Change in working capital-$-48.4M-$-18.9M$20.6M-$-90.1M-$-48.1M
Accounts receivable$21.6M$4.3M-$-12.6M-$-55.5M-$-31.4M
Inventory-$-6.6M-$-11.8M$83M-$-98.5M-$-62M
Accounts payable-$-32.8M-$-4.5M-$-26.9M$54.2M$90.2M
Net cash provided by operating activities$138.3M$184.5M$207.3M$81.7M$93.2M
Investments in property, plant and equipment-$-50.3M-$-62.3M-$-77.2M-$-42.3M-$-39.1M
Acquisitions, net-$-700K-$-200K-$-34.7M$2M$3M
Net cash used for investing activities-$-75.1M-$-62M-$-111.8M-$-42.1M-$-36.2M
Common stock issued$500K$2.1M$900K$2.2M$10.1M
Common stock repurchased-$-23.9M-$-700K-$-1.1M-$-5.9M-$-800K
Dividends paid-$-42.4M-$-38.8M-$-35.1M-$-31.7M-$-28.8M
Net cash used for financing activities-$-63.9M-$-35.3M-$-39M-$-33.7M-$-20M
Net change in cash$3.3M$85.5M$56.6M$5.3M$36.5M
Cash at end of period$292.5M$289.2M$203.7M$147.1M$141.8M
Operating cash flow$138.3M$184.5M$207.3M$81.7M$93.2M
Capital expenditure-$-50.3M-$-41.4M-$-62.1M-$-42.3M-$-39.1M
Free cash flow$88M$143.1M$145.2M$39.4M$54.1M
USD millions

Line items

    USD millions

    Line items

      USD millions

      Line items

        About Innospec Inc.

        Innospec Inc., founded in 1938 as Octel Corp. and rebranded in January 2006, is a global company headquartered in Englewood, Colorado. It focuses on the creation, production, formulation, promotion, and distribution of unique chemical products. The company's operations span across the United States, the wider North American continent, the United Kingdom, continental Europe, and various international markets. Innospec's business is organized into distinct divisions. The Fuel Specialties segment provides a portfolio of specialized chemical additives engineered for various fuel applications. These crucial products are deployed in the functioning of engines for automobiles, maritime vessels, and aviation, as well as for electricity generators and heating oil systems. The Performance Chemicals division delivers sophisticated, technology-driven solutions designed to enhance customer processes or products. This unit primarily caters to sectors such as personal care, household products, agricultural chemicals, and metal recovery. Its Oilfield Services segment concentrates on developing and commercializing chemical solutions essential for fracturing, stimulating, and completing wells. This segment also supplies products that facilitate oil and gas extraction and prevent the loss of drilling mud during operations. Innospec sells its diverse range of products to a broad client base, including companies involved in oil and gas exploration and production, oil refining facilities, fuel producers and end-users, businesses in the personal care and home care industries, formulators of agrochemical and metal extraction products, and various other chemical and industrial enterprises.

        CEO
        Patrick S. Williams
        Employees
        2.45K
        Beta
        0.91

        Included in

        Explore

        Frequently asked questions

        What is the intrinsic value of Innospec Inc. (IOSP)?

        Innospec Inc. (IOSP) is currently fairly valued based on the InvestorsCraft IC model — IC value is within 20% of the price. The exact intrinsic value is available to Pro subscribers. How the IC value is calculated.

        Is IOSP undervalued?

        IOSP trades at a price of $75.56 (Nov 21, 2026): fairly valued — IC value is within 20% of the price.

        How is the intrinsic value calculated?

        InvestorsCraft estimates intrinsic value with four methods: the Chepakovich valuation model (IC), an AI-assisted estimate, the Graham-Dodd formula, and the Graham Formula. How the IC value is calculated.

        How often is this page updated?

        Prices are refreshed each trading day; valuation inputs update when new financial statements are processed. This page was last updated Nov 21, 2026.

        Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Figures marked d are derived from the figures shown — for example upside = IC ÷ price − 1, CAGR over the last five fiscal years, and range bounds are 15-year or peer minimum and maximum.